GCG and type 2 diabetes mellitus: However, mechanistic studies and individual observations in patients with Cushing’s disease suggest that pasireotide-related hyperglycemia responds to anti-diabetic agents following similar protocols recommended for the treatment of T2DM, with a specific focus on GLP-1-based medications.